Burrill & Company: Funding, Team & Investors | Startup Intros

Loading organizations...

Burrill & Company: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Apr 1, 2014	Nora Therapeutics	$18.0M Series B	Heath Lukatch	Frazier Healthcare Partners, Red Tree Venture Capital, Prospect Venture Partners, Rho Ventures, Vivo Capital
Oct 1, 2013	BetterDoctor	$3.0M Seed	—	Accel, Audrey Capital, Bain Capital Ventures, Bessemer Venture Partners, Chemistry VC, Foundry Group, Index Ventures, IVP, London Venture Partners, Moonfire Ventures, NextGen Venture Partners, Techstars, Uncork Capital, Mark Solon, Paul Heydon, Aaron Levie, David Karp, Drew Houston, Jason Seats, Jeff Fluhr, Marc Benioff, Mark Ferguson, Michal Tsur, Moshe Lichtman, Nick Brien, 500 Startups, Dirk Lammerts
Jun 1, 2012	AliveCor	$11.0M Series B	G. Steven Burrill, Vinod Khosla	Oklahoma Life Science Fund, Qualcomm
Jun 1, 2012	Ceptaris Therapeutics	$10.0M Series D	—	Frazier Healthcare Partners, Aperture Venture Partners, BioAdvance, Osage Venture Partners, Palo Alto Investors, Third Point, Vivo Ventures
Apr 12, 2012	WhiteGlove Health	$12.9M Series E	David Wetherell	—
Aug 23, 2011	AliveCor	$3.0M Series A	Bryant Fong	Oklahoma Life Science Fund, Nagraj Kashyap
Aug 1, 2011	Ceptaris Therapeutics	$14.0M Series D	—	Frazier Healthcare Partners, Aperture Venture Partners, Palo Alto Investors, Vivo Ventures
May 1, 2011	Cobalt Technologies	$20.0M Series D	The Whittemore Collection	EQT Life Sciences, VantagePoint Capital Partners, Harris & Harris Group, LSP, Malaysian Life Sciences Capital Fund, Pinnacle Ventures, @Ventures
May 27, 2010	Logical Therapeutics	$16.9M Series C	SV Health Investors	Novitas Capital, Novo Holdings
Oct 23, 2008	Nora Therapeutics	$25.0M Other Equity	—	Prospect Venture Partners, Vivo Ventures